Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Tavis

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Molecules (Basel, Switzerland)|June 27, 2024
<i>N</i>-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase HDimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, et al.
ACS Omega|December 12, 2018
Synthesis and Evaluation of Troponoids as a New Class of AntibioticsFeng Cao, Cari Orth, Maureen J Donlin, et al.
Antiviral Research|November 8, 2016
Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitorsGaofeng Lu, Juan Antonio Villa, Maureen J Donlin, et al.
European Journal of Medicinal Chemistry|August 26, 2021
Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitorsYue Ma, Shujie Zhao, Yujie Ren, et al.
Antiviral Research|November 14, 2017
APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcriptionYanmeng Chen, Jie Hu, Xuefei Cai, et al.
Virology|April 19, 2024
Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshopThomas Tu, Jochen Wettengel, Yuchen Xia, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2024
Efficacy and <i>in vitro</i> pharmacological assessment of novel <i>N</i>-hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitorsMolly E Woodson, Holly F Walden, M Abdul Mottaleb, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 5, 2022
Synthesis of Polyoxygenated Tropolones and their Antiviral Activity against Hepatitis B Virus and Herpes Simplex Virus-1Daniel V Schiavone, Diana M Kapkayeva, Qilan Li, et al.
Antiviral Research|May 27, 2014
Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activityCatherine W Cai, Elena Lomonosova, Eileen A Moran, et al.
Journal of Medicinal Chemistry|December 8, 2025
Design, Synthesis, and Biological Evaluation of Highly Potent Boronic Acid (Boronate Ester)-Bearing Heteroaryldihydropyrimidine Derivatives as HBV Capsid Assembly ModulatorsYu Jin, Yang Sun, Shujie Zhao, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Molecules (Basel, Switzerland)|June 27, 2024
<i>N</i>-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase HDimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, et al.
ACS Omega|December 12, 2018
Synthesis and Evaluation of Troponoids as a New Class of AntibioticsFeng Cao, Cari Orth, Maureen J Donlin, et al.
Antiviral Research|November 8, 2016
Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitorsGaofeng Lu, Juan Antonio Villa, Maureen J Donlin, et al.
European Journal of Medicinal Chemistry|August 26, 2021
Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitorsYue Ma, Shujie Zhao, Yujie Ren, et al.
Antiviral Research|November 14, 2017
APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcriptionYanmeng Chen, Jie Hu, Xuefei Cai, et al.
Virology|April 19, 2024
Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshopThomas Tu, Jochen Wettengel, Yuchen Xia, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2024
Efficacy and <i>in vitro</i> pharmacological assessment of novel <i>N</i>-hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitorsMolly E Woodson, Holly F Walden, M Abdul Mottaleb, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 5, 2022
Synthesis of Polyoxygenated Tropolones and their Antiviral Activity against Hepatitis B Virus and Herpes Simplex Virus-1Daniel V Schiavone, Diana M Kapkayeva, Qilan Li, et al.
Antiviral Research|May 27, 2014
Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activityCatherine W Cai, Elena Lomonosova, Eileen A Moran, et al.
Journal of Medicinal Chemistry|December 8, 2025
Design, Synthesis, and Biological Evaluation of Highly Potent Boronic Acid (Boronate Ester)-Bearing Heteroaryldihydropyrimidine Derivatives as HBV Capsid Assembly ModulatorsYu Jin, Yang Sun, Shujie Zhao, et al.
Pageof 10